A large Mayo Clinic study finds that treating COVID-19 patients with two monoclonal antibodies — casirivimab and imdevimab — can help avoid hospitalization.
COVID-19: Monoclonal antibody combo reduces hospitalization
Posted in biotech/medical
Posted in biotech/medical
A large Mayo Clinic study finds that treating COVID-19 patients with two monoclonal antibodies — casirivimab and imdevimab — can help avoid hospitalization.